Hemarina is a startup based in France, most recent round Series-c-plus, 1 tracked investor.
Based in France, Hemarina is a startup founded in 2002. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Hemarina is a French biotech company developing therapeutic products based on the extracellular hemoglobin of the marine annelid Arenicola marina. These products aim to improve tissue and organ oxygenation for applications in transplantation, wound healing, and other medical fields.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.